Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) EBT (2016 - 2025)

Historic EBT for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $22.6 million.

  • Lemaitre Vascular's EBT rose 5513.02% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.9 million, marking a year-over-year increase of 2720.84%. This contributed to the annual value of $56.9 million for FY2024, which is 4407.85% up from last year.
  • Lemaitre Vascular's EBT amounted to $22.6 million in Q3 2025, which was up 5513.02% from $18.1 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's EBT registered a high of $22.6 million during Q3 2025, and its lowest value of $5.5 million during Q2 2022.
  • Over the past 5 years, Lemaitre Vascular's median EBT value was $10.3 million (recorded in 2023), while the average stood at $11.2 million.
  • As far as peak fluctuations go, Lemaitre Vascular's EBT skyrocketed by 11932.03% in 2021, and later crashed by 4693.45% in 2022.
  • Quarter analysis of 5 years shows Lemaitre Vascular's EBT stood at $7.9 million in 2021, then fell by 1.35% to $7.8 million in 2022, then soared by 45.08% to $11.3 million in 2023, then grew by 23.94% to $14.0 million in 2024, then soared by 60.99% to $22.6 million in 2025.
  • Its EBT was $22.6 million in Q3 2025, compared to $18.1 million in Q2 2025 and $14.2 million in Q1 2025.